Rare diseases
Investigational molecules
Locations
Back to Denmark1 426 clinical trials in Herlev, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer
DenmarkStudy on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder
DenmarkStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
DenmarkStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
BelgiumStudy of Regorafenib with Chemotherapy for Newly Diagnosed Patients with Metastatic Ewing Sarcoma
DenmarkStudy of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
DenmarkStudy of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations
FranceStudy on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia
DenmarkStudy on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa
DenmarkStudy of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer
DenmarkStudy of IO102-IO103 and Pembrolizumab for Patients with Resectable Melanoma and Head and Neck Squamous Cell Carcinoma
DenmarkStudy of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in endometrial, prostate, and bladder cancers. Studies are evaluating novel combination therapies and immunological approaches.
Research aims to improve treatment outcomes and survival rates through targeted therapeutic approaches.
Comprehensive research into heart failure prevention and treatment of metabolic conditions, including studies on innovative drug combinations and biomarker-targeted approaches.
Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.
Studies examining vaccine effectiveness and preventive treatments, particularly in meningococcal and varicella infections. Research includes both pediatric and adult populations.
Emphasis on developing safe and effective preventive measures for infectious diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
